Home » Stocks » NOVN

Novan, Inc. (NOVN)

Stock Price: $7.48 USD -0.55 (-6.85%)
Updated Jul 29, 2021 4:00 PM EDT - Market closed
After-hours: $7.64 +0.16 (2.14%) Jul 29, 4:59 PM
Market Cap 151.02M
Revenue (ttm) 4.53M
Net Income (ttm) -32.08M
Shares Out 15.00M
EPS (ttm) -2.53
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day July 29
Last Price $7.48
Previous Close $8.03
Change ($) -0.55
Change (%) -6.85%
Day's Open 8.09
Day's Range 7.48 - 8.14
Day's Volume 882,919
52-Week Range 3.00 - 25.90

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

– Company previously reported positive topline efficacy and favorable safety data at Week 12 from B-SIMPLE4 in June 2021, with primary endpoint achieving statistical significance with p-value less than ...

1 day ago - GlobeNewsWire

CHICAGO--(BUSINESS WIRE)--Pritzker Private Capital (“PPC”), a leader in family direct investing, today announced the appointment of Paula Brown Stafford to the Pritzker Advisory Board. Ms. Stafford, cur...

1 week ago - Business Wire

DURHAM, N.C., June 24, 2021 (GLOBE NEWSWIRE) -- Novan, Inc. (“the Company” or “Novan”) (Nasdaq: NOVN), today announced that as part of the annual reconstitution of the Russell stock indexes, Novan has b...

1 month ago - GlobeNewsWire

DURHAM, N.C., June 21, 2021 (GLOBE NEWSWIRE) -- Novan, Inc. (the “Company" or "Novan") (NASDAQ:NOVN) today announced the closing of the Company's previously announced underwritten public offering (the “...

1 month ago - GlobeNewsWire

Novan Inc (NASDAQ: NOVN) priced its previously announced public offering of 3.6 million shares at $11/share for gross proceeds of approximately $40 million. The offer price represents a 21% discount on ...

1 month ago - Benzinga

DURHAM, N.C., June 17, 2021 (GLOBE NEWSWIRE) -- Novan, Inc. (the “Company" or "Novan") (NASDAQ:NOVN) today announced the pricing of the Company's previously announced underwritten public offering (the “...

1 month ago - GlobeNewsWire

DURHAM, N.C., June 16, 2021 (GLOBE NEWSWIRE) -- Novan, Inc. (the “Company” or “Novan”) (NASDAQ: NOVN) today announced a proposed underwritten public offering of its common stock (the “Offering”). All sh...

1 month ago - GlobeNewsWire

Are these former penny stocks on your watch list right now? The post 4 Penny Stocks To Watch Hit It Big In 2021, 1 Up Over 2,200% Right Now appeared first on Penny Stocks to Buy, Picks, News and Informa...

Other stocks mentioned: GTBP, OCGN, VXRT
1 month ago - PennyStocks

NOVN stock is flexing 70% gains as the company shows off the wild success of its topical treatment for a common, contagious infection. The post NOVN Stock: The Positive Trial Results Sending Novan Skyro...

1 month ago - InvestorPlace

Novan Inc. (NASDAQ: NOVN) shares are trading higher Friday after the company reported that B-SIMPLE4 pivotal Phase 3 trial of SB206 achieved significance for the primary endpoint with no adverse events....

1 month ago - Benzinga

Novan Inc (NASDAQ:NOVN) shares are trading higher by 59% at $14.37 Friday morning after the company reported the B-SIMPLE4 pivotal Phase 3 trial of SB206 achieved statistical significance for the primar...

1 month ago - Benzinga

Novan Inc (NASDAQ: NOVN) has announced positive topline efficacy and safety results from the B-SIMPLE4 Phase 3 trial evaluating SB206, a topical antiviral gel, for the treatment of molluscum contagiosum...

1 month ago - Benzinga

– B-SIMPLE4 achieves statistical significance for the primary endpoint with p-value less than 0.0001 –

1 month ago - GlobeNewsWire

– Data indicate that berdazimer sodium prevents progression of SARS-CoV-2 infection in two independent in vivo transmission studies –

1 month ago - GlobeNewsWire

– Positive in vitro results demonstrate antimicrobial effect of NVN4100 against a wide variety of bacteria and suggest a promising bactericidal mode of action –

1 month ago - GlobeNewsWire

Biotech penny stocks are heating up right now; here's 4 to watch The post Best Biotech Penny Stocks to Buy Under $5? 4 To Check Out in May appeared first on Penny Stocks to Buy, Picks, News and Informat...

Other stocks mentioned: EVFM, NERV, OBLN
2 months ago - PennyStocks

– Topline efficacy results for ongoing Phase 3 study evaluating SB206 as a treatment for molluscum on track for targeted readout before the end of Q2 2021 –

2 months ago - GlobeNewsWire

– Topline data on track for readout before the end of Q2 2021 –

2 months ago - GlobeNewsWire

MORRISVILLE, N.C., March 05, 2021 (GLOBE NEWSWIRE) -- Novan, Inc. (“the Company” or “Novan”) (Nasdaq: NOVN), today announced that Paula Brown Stafford, President and Chief Executive Officer of Novan, wi...

4 months ago - GlobeNewsWire

– B-SIMPLE4 pivotal Phase 3 trial evaluating SB206 as a treatment for molluscum contagiosum progressing with top-line efficacy results targeted before the end of Q2 2021 –

5 months ago - GlobeNewsWire

– Topline data on track for targeted readout before the end of Q2 2021 –

5 months ago - GlobeNewsWire

MORRISVILLE, N.C., Jan. 29, 2021 (GLOBE NEWSWIRE) -- Novan, Inc. (“the Company” or “Novan”) (Nasdaq: NOVN), today announced that it has received written notice from The Nasdaq Stock Market LLC (“Nasdaq”...

6 months ago - GlobeNewsWire

– B-SIMPLE4 pivotal Phase 3 study in molluscum contagiosum reaches 90% enrollment with topline data targeted for Q2 2021 –

6 months ago - GlobeNewsWire

NEW YORK, Jan. 13, 2021 /PRNewswire/ -- Purcell Julie & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of fiduciary duty cl...

6 months ago - PRNewsWire

MORRISVILLE, N.C., Jan. 08, 2021 (GLOBE NEWSWIRE) -- Novan, Inc. (“the Company” or “Novan”) (Nasdaq: NOVN), today announced that Paula Brown Stafford, President and Chief Executive Officer of Novan, wil...

6 months ago - GlobeNewsWire

– Catalent has a proven track record of accelerating molecules from early development through commercial manufacturing –

7 months ago - GlobeNewsWire

– Completion of patient enrollment targeted for Q1 2021 with readout of topline results targeted for Q2 2021 –

7 months ago - GlobeNewsWire

NEW YORK, Dec. 14, 2020 /PRNewswire/ -- Purcell Julie & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of fiduciary duty cl...

7 months ago - PRNewsWire

– T rading on Nasdaq Capital Market is expected to begin on November 5, 2020 –

8 months ago - GlobeNewsWire

– Lead product candidate, SB206 currently being evaluated in B-SIMPLE4 pivotal Phase 3 study in molluscum contagiosum with topline data targeted for Q2 2021 –

8 months ago - GlobeNewsWire

- Live moderated video webcast discussion between members of management and Key Opinion Leader, John Browning, MD, FAAD, FAAP, MBA on Tuesday October 27th at 12:00 PM ET - Live moderated video webcast d...

9 months ago - GlobeNewsWire

- F irst demonstration of antiviral effect of nitric oxide -based medicine against SARS-CoV-2 in an in vitro model that mimics the human airway epithelium

9 months ago - GlobeNewsWire

- John M. Gay , V ice P resident , Finance and Corporate Controller with over 20 years of financial and accounting experience appointed as Chief Financial Officer

10 months ago - GlobeNewsWire

- Lead product candidate, SB206 currently being evaluated in B-SIMPLE4 pivotal Phase 3 study in molluscum contagiosum with topline data targeted for Q2 2021 -

10 months ago - GlobeNewsWire

- Live video webcast with President and CEO, Paula Brown Stafford, on Monday, September 14th at 4:00 PM EDT -

10 months ago - GlobeNewsWire

- Topline results targeted for Q2 2021, less than a year away -

10 months ago - GlobeNewsWire

- Clinical sites actively enrolling patients -

10 months ago - GlobeNewsWire

MORRISVILLE, N.C., July 28, 2020 (GLOBE NEWSWIRE) -- Novan, Inc. ("the Company" or "Novan") (Nasdaq: NOVN), today announced an expanded role of Paula Brown Stafford, President and Chief Executive O...

1 year ago - GlobeNewsWire

MORRISVILLE, N.C., July 23, 2020 (GLOBE NEWSWIRE) -- Novan, Inc. ("the Company" or "Novan") (Nasdaq: NOVN), today announced that it will host a live audio webcast of the Company’s 2020 Annual Meeting ...

1 year ago - GlobeNewsWire

MORRISVILLE, N.C., June 25, 2020 (GLOBE NEWSWIRE) -- Novan, Inc. ("the Company" or "Novan") (Nasdaq:NOVN) today announced that the Company anticipates that its current cash position will be sufficient...

1 year ago - GlobeNewsWire

MORRISVILLE, N.C., June 24, 2020 (GLOBE NEWSWIRE) -- Novan, Inc. (“the Company” or “Novan”) (Nasdaq:NOVN) today announced that Paula Brown Stafford, the Company’s President and Chief Executive Officer...

1 year ago - GlobeNewsWire

MORRISVILLE, N.C., April 30, 2020 (GLOBE NEWSWIRE) -- Novan, Inc. (“the Company” or “Novan”) (Nasdaq:NOVN) today announced that the Company has received meeting minutes from the April 1, 2020 Type C m...

1 year ago - GlobeNewsWire

MORRISVILLE, N.C., April 20, 2020 (GLOBE NEWSWIRE) -- Novan, Inc. (“the Company” or “Novan”) (Nasdaq:NOVN) today announced that it has engaged H.C. Wainwright & Co., LLC (“H.C. Wainwright & Co.”) to a...

1 year ago - GlobeNewsWire

Top Ranked Momentum Stocks to Buy for April 6th

Other stocks mentioned: CHWY, FRO, TNK
1 year ago - Zacks Investment Research

MORRISVILLE, N.C., April 03, 2020 (GLOBE NEWSWIRE) -- Novan, Inc. (“the Company” or “Novan”) (Nasdaq:NOVN) today announced that the Company has conducted its Type C meeting with the U.S. Food and Drug...

1 year ago - GlobeNewsWire

Top Ranked Momentum Stocks to Buy for April 2nd

Other stocks mentioned: AYTU, DHT, EURN
1 year ago - Zacks Investment Research

Top Ranked Momentum Stocks to Buy for March 30th

Other stocks mentioned: FTSV, MRNA, VIRT
1 year ago - Zacks Investment Research

MORRISVILLE, N.C., March 26, 2020 (GLOBE NEWSWIRE) -- Novan, Inc. ("the Company" or "Novan") (NASDAQ:NOVN) today announced the closing of the Company’s previously announced registered direct offering ...

1 year ago - GlobeNewsWire

MORRISVILLE, N.C., March 24, 2020 (GLOBE NEWSWIRE) -- Novan, Inc. ("the Company" or "Novan") (NASDAQ:NOVN) today announced that it has entered into definitive agreements with several institutional and...

1 year ago - GlobeNewsWire

MORRISVILLE, N.C., March 23, 2020 (GLOBE NEWSWIRE) -- Novan, Inc. (“the Company” or “Novan”) (Nasdaq:NOVN) today announced data from the prospectively planned safety evaluation through Week 24 as part...

1 year ago - GlobeNewsWire

About NOVN

Novan, Inc., a clinical development-stage biotechnology company, provides nitric oxide-based therapies to treat dermatological and oncovirus-mediated diseases. Its clinical stage dermatology drug candidates include SB204, a topical monotherapy for the treatment of acne vulgaris; SB206, a topical anti-viral gel for the treatment of viral skin infections; SB208, a topical broad-spectrum anti-fungal gel for the treatment of fungal infections of the skin and nails, including athlete's foot and fungal nail infections; and SB414, a topical cream-base... [Read more...]

Industry
Biotechnology
IPO Date
Sep 21, 2016
CEO
Paula Stafford
Employees
23
Stock Exchange
NASDAQ
Ticker Symbol
NOVN
Full Company Profile

Financial Performance

In 2020, Novan's revenue was $4.92 million, an increase of 0.49% compared to the previous year's $4.90 million. Losses were -$29.29 million, -3.57% less than in 2019.

Financial Statements

Analyst Forecasts

According to one analyst, the rating for Novan stock is "Buy" and the 12-month stock price forecast is 47.00.

Price Target
$47.00
Analyst Consensus: Buy